About
CKD Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
1,667
By Phase
PHASE3: 2
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05836220Lead Sponsor
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
PHASE3Completed
412 participants
Started: May 15, 2023 · Completed: Aug 5, 2025
NCT05832931Lead Sponsor
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
PHASE3Completed
362 participants
Started: Apr 28, 2023 · Completed: Jul 28, 2025
NCT03239834Collaborator
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
N/ACompleted
893 participants
Started: Sep 7, 2017 · Completed: Dec 20, 2020
Locations (1)
Headquarters
Raleigh, NC, United States
Map
Loading map...